TCF — Theracryf Cashflow Statement
0.000.00%
Last trade - 00:00- £4.51m
- £1.02m
Annual cashflow statement for Theracryf, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.21 | -3.17 | -5.01 | -3.57 | -2.08 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -0.112 | 0.122 | 0.059 | 0.137 | 0.112 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.381 | 0.447 | 0.807 | 0.422 | -0.463 |
| Change in Accounts Receivable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.93 | -2.58 | -4.13 | -3 | -2.37 |
| Capital Expenditures | -0.005 | -0.003 | -0.001 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -6 | 1.5 | 4.62 | 0 | -2.08 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -6 | 1.5 | 4.62 | 0 | -2.08 |
| Financing Cash Flow Items | -0.717 | 0 | — | — | -0.605 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 10.4 | 0 | — | — | 4.55 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.46 | -1.08 | 0.49 | -3 | 0.105 |